{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:44:54Z","timestamp":1794915894140,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To review the trend of microbial isolates for postoperative endophthalmitis (POE) in the United Kingdom (UK) and determine the sensitivity to current empirical intravitreal antibiotic treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a long term multicentre consecutive case review of POE across 3 geographically distant tertiary eye centres in the UK: Sunderland Eye Infirmary (2000\u20132022), Oxford Eye Hospital (2016\u20132022), and Southampton General Hospital (2016\u20132022). Data on the microbial samples taken and results including sensitivities to antibiotics agents given were collected. Poisson regression was used to analyse microbial trends and outcomes were considered statistically significant at a level of\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      179 consecutive eyes of 177 patients with POE met our inclusion criteria. The most common primary procedure was phacoemulsification and IOL insertion followed by intravitreal injections. 104 (58.1%) were culture positive and most were Gram-positive bacteria (85, 81.7%). The microbial trend consistently showed\n                      <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                      and unspecified coagulase-negative\n                      <jats:italic>Staphylococci<\/jats:italic>\n                      to be the most prevalent pathogens. Poisson regression showed no statistically significant change in any of the bacterial isolates over our study period. Antibiotic sensitivity data was available for 74% of the culture positive samples (77\/104). All Gram-positive bacteria (68\/68, 100%) and most (8\/9, 88.9%) Gram-negative bacteria were sensitive to the empirical antibiotics (Vancomycin and Ceftazidime\/Amikacin) given at presentation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most of the bacterial isolates causing POE in the UK are Gram-positive bacteria, and the trend has remained stable over more than two decades. Current empirical treatment with intravitreal Vancomycin and Ceftazidime\/Amikacin provides effective broad coverage for the vast majority of cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-025-03673-w","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T13:17:26Z","timestamp":1739366246000},"page":"1470-1475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long term analysis of microbiological isolates and antibiotic susceptibilities in acute-onset postoperative endophthalmitis: a UK multicentre study"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-0233","authenticated-orcid":false,"given":"Boon Lin","family":"Teh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-573X","authenticated-orcid":false,"given":"Ariel Yuhan","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Settle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-4305","authenticated-orcid":false,"given":"Andrew J.","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0351-6673","authenticated-orcid":false,"given":"Peter","family":"Charbel Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-3089","authenticated-orcid":false,"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"3673_CR1","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jcrs.2013.06.014","volume":"39","author":"A Behndig","year":"2013","unstructured":"Behndig A, Cochener B, G\u00fcell JL, Kodjikian L, Mencucci R, Nuijts RM, et al. Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg. 2013;39:1421\u201331.","journal-title":"J Cataract Refract Surg"},{"key":"3673_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.preteyeres.2012.03.004","volume":"31","author":"A Sadaka","year":"2012","unstructured":"Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog Retin Eye Res. 2012;31:316\u201331.","journal-title":"Prog Retin Eye Res"},{"key":"3673_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcrs.2014.04.040","volume":"41","author":"MM Nentwich","year":"2015","unstructured":"Nentwich MM, Ta CN, Kreutzer TC, Li B, Schwarzbach F, Yactayo-Miranda YM, et al. Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution. J Cataract Refract Surg. 2015;41:58\u201366.","journal-title":"J Cataract Refract Surg"},{"key":"3673_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S095026881400034X","volume":"143","author":"MA Asencio","year":"2015","unstructured":"Asencio MA, Huertas M, Carranza R, Tenias JM, Celis J, Gonzalez-Del Valle F. A case-control study of post-operative endophthalmitis diagnosed at a Spanish hospital over a 13-year-period. Epidemiol Infect. 2015;143:178\u201383.","journal-title":"Epidemiol Infect"},{"key":"3673_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jamaophthalmol.2016.1351","volume":"134","author":"V Daien","year":"2016","unstructured":"Daien V, Papinaud L, Gillies MC, Domerg C, Nagot N, Lacombe S, et al. Effectiveness and Safety of an Intracameral Injection of Cefuroxime for the Prevention of Endophthalmitis After Cataract Surgery With or Without Perioperative Capsular Rupture. JAMA Ophthalmol. 2016;134:810\u20136.","journal-title":"JAMA Ophthalmol"},{"key":"3673_CR6","doi-asserted-by":"crossref","unstructured":"Pathengay A, Khera M, Das T, Sharma S, Miller D, Flynn HW Jr. Acute Postoperative Endophthalmitis Following Cataract Surgery: A Review. Asia Pac J Ophthalmol. 2012;1:35\u201342.","DOI":"10.1097\/APO.0b013e31823e574b"},{"key":"3673_CR7","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/s41433-021-01646-3","volume":"36","author":"R Chopra","year":"2022","unstructured":"Chopra R, Preston GC, Keenan TDL, Mulholland P, Patel PJ, Balaskas K, et al. Intravitreal injections: past trends and future projections within a UK tertiary hospital. Eye. 2022;36:1373\u20138.","journal-title":"Eye"},{"key":"3673_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1136\/bjophthalmol-2011-300338","volume":"96","author":"TD Keenan","year":"2012","unstructured":"Keenan TD, Wotton CJ, Goldacre MJ. Trends over time and geographical variation in rates of intravitreal injections in England. Br J Ophthalmol. 2012;96:413\u20138.","journal-title":"Br J Ophthalmol"},{"key":"3673_CR9","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1111\/aos.14511","volume":"99","author":"A Malmin","year":"2021","unstructured":"Malmin A, Syre H, Ushakova A, Utheim TP, Forsaa VA. Twenty years of endophthalmitis: Incidence, aetiology and clinical outcome. Acta Ophthalmologica. 2021;99:e62\u2013e9.","journal-title":"Acta Ophthalmologica"},{"key":"3673_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41433-021-01886-3","volume":"37","author":"AY Ong","year":"2023","unstructured":"Ong AY, Rigaudy A, Toufeeq S, Robins J, Shalchi Z, Bindra MS, et al. Intravitreal injections as a leading cause of acute postoperative endophthalmitis-a regional survey in England. Eye. 2023;37:163\u20139.","journal-title":"Eye"},{"key":"3673_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jamaophthalmol.2024.2749","volume":"142","author":"BL VanderBeek","year":"2024","unstructured":"VanderBeek BL, Chen Y, Tomaiuolo M, Deaner JD, Syed ZA, Acharya B, et al. Endophthalmitis Rates and Types of Treatments After Intraocular Procedures. JAMA Ophthalmol. 2024;142:827\u201334.","journal-title":"JAMA Ophthalmol"},{"key":"3673_CR12","first-page":"1479","volume":"113","author":"Results of the Endophthalmitis Vitrectomy Study","year":"1995","unstructured":"Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group Arch Ophthalmol. 1995;113:1479\u201396.","journal-title":"Endophthalmitis Vitrectomy Study Group Arch Ophthalmol"},{"key":"3673_CR13","unstructured":"Barry P, Cordov\u00e9s L, Gardner S. ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions. European Society of Cataract and Refractive Surgeons. 2013, pp. 1\u201344. https:\/\/www.escrs.org\/media\/uljgvpn1\/english_2018_updated.pdf"},{"key":"3673_CR14","doi-asserted-by":"publisher","first-page":"101218","DOI":"10.1016\/j.preteyeres.2023.101218","volume":"97","author":"T Das","year":"2023","unstructured":"Das T, Joseph J, Simunovic MP, Grzybowski A, Chen KJ, Dave VP, et al. Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives. Progress Retinal Eye Res. 2023;97:101218.","journal-title":"Progress Retinal Eye Res"},{"key":"3673_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/IAE.0000000000001603","volume":"37","author":"N Relhan","year":"2017","unstructured":"Relhan N, Pathengay A, Schwartz SG, Flynn HW Jr. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. Retina. 2017;37:811\u20138.","journal-title":"Retina"},{"key":"3673_CR16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2147\/IDR.S314647","volume":"14","author":"C Liu","year":"2021","unstructured":"Liu C, Ding B, Ji J, Wang Z, Chen H, Cao W. Microbial Spectrum and Resistance Patterns in Ocular Infections: A 15-Year Review in East China. Infect Drug Resist. 2021;14:2165\u201371.","journal-title":"Infect Drug Resist"},{"key":"3673_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/eye.2015.3","volume":"29","author":"AC Day","year":"2015","unstructured":"Day AC, Donachie PH, Sparrow JM, Johnston RL. The Royal College of Ophthalmologists\u2019 National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye. 2015;29:552\u201360.","journal-title":"Eye"},{"key":"3673_CR18","doi-asserted-by":"publisher","first-page":"101221","DOI":"10.1016\/j.eclinm.2021.101221","volume":"41","author":"EclinicalMedicine","year":"2021","unstructured":"EclinicalMedicine. Antimicrobial resistance: a top ten global public health threat. eClinicalMedicine. 2021;41:101221.","journal-title":"eClinicalMedicine"},{"key":"3673_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/IAE.0000000000003773","volume":"43","author":"R Velez-Montoya","year":"2023","unstructured":"Velez-Montoya R, Monroy-Esquivel L, Ortiz-Guevara R, Quiroz-Mercado H, Fromow-Guerra J, Mexican Endophthalmitis Study Group. ALTERNATIVE INTRAVITREAL ANTIBIOTICS: A Systematic Review for Consideration in Recalcitrant or Resistant Endophthalmitis. Retina. 2023;43:1433\u201347.","journal-title":"Retina"},{"key":"3673_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95458-w","volume":"11","author":"KJ Chen","year":"2021","unstructured":"Chen KJ, Sun MH, Hou CH, Chen HC, Chen YP, Wang NK, et al. Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin. Sci Rep. 2021;11:15878.","journal-title":"Sci Rep"},{"key":"3673_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.survophthal.2018.02.003","volume":"63","author":"B Clarke","year":"2018","unstructured":"Clarke B, Williamson TH, Gini G, Gupta B. Management of bacterial postoperative endophthalmitis and the role of vitrectomy. Surv Ophthalmol. 2018;63:677\u201393.","journal-title":"Surv Ophthalmol"},{"key":"3673_CR22","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.jcrs.2008.05.043","volume":"34","author":"D Seal","year":"2008","unstructured":"Seal D, Reischl U, Behr A, Ferrer C, Ali\u00f3 J, Koerner RJ, Barry P, ESCRS Endophthalmitis Study G. Laboratory diagnosis of endophthalmitis: comparison of microbiology and molecular methods in the European Society of Cataract & Refractive Surgeons multicenter study and susceptibility testing. J Cataract Refract Surg. 2008;34:1439\u201350.","journal-title":"J Cataract Refract Surg"},{"key":"3673_CR23","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bjophthalmol-2014-305030","volume":"98","author":"TP Moloney","year":"2014","unstructured":"Moloney TP, Park J. Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review. Brit J Ophthalmol. 2014;98:1492\u20137.","journal-title":"Brit J Ophthalmol"},{"key":"3673_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4103\/ijo.IJO_509_17","volume":"65","author":"P Lalitha","year":"2017","unstructured":"Lalitha P, Sengupta S, Ravindran RD, Sharma S, Joseph J, Ambiya V, et al. A literature review and update on the incidence and microbiology spectrum of postcataract surgery endophthalmitis over past two decades in India. Indian J Ophthalmol. 2017;65:673\u20137.","journal-title":"Indian J Ophthalmol"},{"key":"3673_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0255-0857.180280","volume":"34","author":"H Bhattacharjee","year":"2016","unstructured":"Bhattacharjee H, Bhattacharjee K, Gogoi K, Singh M, Singla BG, Yadav A. Microbial profile of the vitreous aspirates in culture proven exogenous endophthalmitis: A 10-year retrospective study. Indian J Med Microbiol. 2016;34:153\u20138.","journal-title":"Indian J Med Microbiol"},{"key":"3673_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajo.2013.01.027","volume":"156","author":"AM Schimel","year":"2013","unstructured":"Schimel AM, Miller D, Flynn HW Jr. Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol. 2013;156:50\u20132.e1.","journal-title":"Am J Ophthalmol"},{"key":"3673_CR27","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41433-019-0380-8","volume":"33","author":"J Joseph","year":"2019","unstructured":"Joseph J, Sontam B, Guda SJM, Gandhi J, Sharma S, Tyagi M, et al. Trends in microbiological spectrum of endophthalmitis at a single tertiary care ophthalmic hospital in India: a review of 25 years. Eye. 2019;33:1090\u20135.","journal-title":"Eye"},{"key":"3673_CR28","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/bjophthalmol-2011-301439","volume":"96","author":"MP Simunovic","year":"2012","unstructured":"Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol. 2012;96:862\u20136.","journal-title":"Br J Ophthalmol"},{"key":"3673_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/ceo.13345","volume":"47","author":"AP Ong","year":"2019","unstructured":"Ong AP, Angbue Te Te N, Zagora SL, Symes RJ, Yates W, Chang AA, et al. Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora. Clinical Exp Ophthalmol. 2019;47:57\u201362.","journal-title":"Clinical Exp Ophthalmol"},{"key":"3673_CR30","doi-asserted-by":"crossref","unstructured":"Zhang DA, DeGeus DS, Hogden DM, et al. The association between endophthalmitis risk following a variety of intra-ocular procedures and defensin gene profile. AJO Int. 2024;1:100034.","DOI":"10.1016\/j.ajoint.2024.100034"},{"key":"3673_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrs.2006.10.022","volume":"33","author":"SP Mollan","year":"2007","unstructured":"Mollan SP, Gao A, Lockwood A, Durrani OM, Butler L. Postcataract endophthalmitis: Incidence and microbial isolates in a United Kingdom region from 1996 through 2004. J Cataract Refract Surg. 2007;33:265\u20138.","journal-title":"J Cataract Refract Surg"},{"key":"3673_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.oret.2020.03.009","volume":"4","author":"HL Feng","year":"2020","unstructured":"Feng HL, Robbins CB, Fekrat S. A Nine-Year Analysis of Practice Patterns, Microbiologic Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis. Ophthalmol Retina. 2020;4:555\u20139.","journal-title":"Ophthalmol Retina"},{"key":"3673_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40662-017-0083-9","volume":"4","author":"C Sjoholm-Gomez de Liano","year":"2017","unstructured":"Sjoholm-Gomez de Liano C, Soberon-Ventura VF, Salcedo-Villanueva G, Santos-Palacios A, Guerrero-Naranjo JL, Fromow-Guerra J, et al. Sensitivity, specificity and predictive values of anterior chamber tap in cases of bacterial endophthalmitis. Eye Vis. 2017;4:18.","journal-title":"Eye Vis"},{"key":"3673_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/sj.eye.6700645","volume":"18","author":"S Kamalarajah","year":"2004","unstructured":"Kamalarajah S, Silvestri G, Sharma N, Khan A, Foot B, Ling R, et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye. 2004;18:580\u20137.","journal-title":"Eye"},{"key":"3673_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22416-4","volume":"8","author":"P Kirstahler","year":"2018","unstructured":"Kirstahler P, Bjerrum SS, Friis-M\u00f8ller A, la Cour M, Aarestrup FM, Westh H, et al. Genomics-Based Identification of Microorganisms in Human Ocular Body Fluid. Sci Rep. 2018;8:4126.","journal-title":"Sci Rep"},{"key":"3673_CR36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ajo.2020.03.008","volume":"217","author":"CS Lee","year":"2020","unstructured":"Lee CS, Hong B, Kasi SK, Aderman C, Talcott KE, Adam MK, et al. Prognostic Utility of Whole-Genome Sequencing and Polymerase Chain Reaction Tests of Ocular Fluids in Postprocedural Endophthalmitis. Am J Ophthalmol. 2020;217:325\u201334.","journal-title":"Am J Ophthalmol"},{"key":"3673_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37502-w","volume":"9","author":"D Deshmukh","year":"2019","unstructured":"Deshmukh D, Joseph J, Chakrabarti M, Sharma S, Jayasudha R, Sama KC, et al. New insights into culture negative endophthalmitis by unbiased next generation sequencing. Sci Rep. 2019;9:844.","journal-title":"Sci Rep"},{"key":"3673_CR38","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/08820538.2022.2113101","volume":"38","author":"P Naik","year":"2023","unstructured":"Naik P, Gandhi J, Joseph J. Recent Advances and Ongoing Challenges in the Diagnosis of Culture Negative Endophthalmitis. Semin Ophthalmol. 2023;38:92\u20138.","journal-title":"Semin Ophthalmol"},{"key":"3673_CR39","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ajo.2019.06.008","volume":"207","author":"SN Patel","year":"2019","unstructured":"Patel SN, Storey PP, Pancholy M, Obeid A, Wibbelsman TD, Levin H, et al. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection. Am J Ophthalmol. 2019;207:224\u201331.","journal-title":"Am J Ophthalmol"},{"key":"3673_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oret.2020.06.028","volume":"5","author":"SN Patel","year":"2021","unstructured":"Patel SN, Storey PP, Levin H, Pancholy M, Obeid A, Wibbelsman TD, et al. Endophthalmitis after Cataract Surgery: Changes in Management Based on Microbiologic Cultures. Ophthalmol Retina. 2021;5:16\u201322.","journal-title":"Ophthalmol Retina"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03673-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03673-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03673-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:25:29Z","timestamp":1747643129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-025-03673-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3673"],"URL":"https:\/\/doi.org\/10.1038\/s41433-025-03673-w","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DHS has received consulting fees from Alcon, Gyroscope Therapeutics (a Novartis company), Alimera, Complement therapeutics, BVI, and Roche, and research funding from Alcon, Gyroscope Therapeutics, Boehringer Ingelheim, DORC, Roche, and Bayer \u2013 all unrelated to this project. The other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}